02-Mar-2021

Antifungal Drugs Market and Factors Behind its Growing Landscape – Industry Analysis by Top Vendors, Size, Growth Factors and Forecast to 2027

An antifungal medication also antimycotic medication is a pharmaceutical fungicide or fungistatic used to prevent or treat mycosis such as ringworm, athlete’s foot, candidiasis, or severe systematic infections. Common fungal infections such as fungal nail infection, vaginal infection, and ringworm usually occur on the external surface of the body, while certain fungal invasive infections occur inside the tissue of body or in an internal organ such as lungs and brain. Generally, fungal infection is associated with a weak immune system, with people suffering from HIV and AIDS, and those undergoing high dosage chemotherapy more susceptible to invasive fungal infections. Antifungal drugs work against fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.

For more Information, Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/237

According to the Centers for Disease Control and Prevention (CDC), around 1 million people get infected worldwide by cryptococcal meningitis, which is a brain infection caused by fungus Cryptococcus and it subsequently leads to 625,000 deaths. These cases are mainly reported in sub-Saharan Africa. Moreover, the histoplasmosis infection mostly occurs in the U.S. and some portion of Central and South America. According to the same source, the histoplasmosis is a common infection observed in people with HIV and AIDS. In case of histoplasmosis, late diagnosis and treatment can be fatal.

The global antifungal drugs market recorded double-digit Y-o-Y growth in 2016 and it is expected witness steady growth rate in the near future. This growth is attributed to increasing prevalence of infections and changing climatic conditions, in turn increasing incidence of fungal infections. Moreover, Latin and South America have witnessed more growth in anti-fungal drugs revenue than North America in the recent past.

Increasing accessibility to low-cost over-the-counter (OTC) antifungal drugs creates a highly lucrative environment for growth of the global antifungal drugs market.

Quick Buy – Antifungal Drugs Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/237

Global antifungal drugs market taxonomy:

By Drug Type

Azoles
Echinocandins
Allylamines
Polyenes
Others

By Therapeutic Indication

Dermatophytosis
Candidiasis
Other therapeutic indications

By Geography

North America
Latin America
Europe
Middle East
APAC
Africa

Market Dynamics

Growing incidence of antifungal infections and increasing popularity of OTC drugs to drive growth of the global antifungal drugs market in near the future

Increasing incidence of antifungal infections worldwide is expected to drive growth of the global antifungal drugs market during the forecast period. Changing environment conditions and increasing pollution has led to increasing prevalence of various infections. Moreover, exponential growth of population is expected to boost the demand for antifungal drugs in the near future.

However, presence of counterfeit drugs in different regions around the world is expected to restrain growth of the global antifungal drugs market in the near future.

Read Press Release: https://www.coherentmarketinsights.com/press-release/antifungal-drugs-market-3463

Regional Insights

Among regions, North America accounts for the largest market share in the global antifungal drugs market. This is owing increasing awareness regarding infections and high investment in R&D in the region. Furthermore, emerging economies in Asia Pacific region are expected to exhibit high growth rate over the forecast period, owing to increasing awareness regarding infectious diseases, increasing number of R&D activities, and growing target population.

Moreover, growing popularity of OTC drugs in the region, as they are cost effective for the patients and growing advertisement of antifungal drugs for dermal infections such as for skin infection is expected to propel the global antifungal drugs market over the forecast period. Furthermore, patent expiration of branded drugs will drive the market growth. Increased funding for R&D in developed countries and increased focus on product innovation will further augment market growth.

Key Developments

Major companies in the market are involved in various growth strategies such as collaboration and agreement, in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution of Beasilea’s antifungal treatments. Pfizer will manufacture and distribute drugs for treatment of life-threatening invasive mold infections in Russia, Israel, Europe (excluding Nordics), and Turkey.
Key players in the market are adopting various business strategies such as research and development, in order to expand their product portfolio. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from first interim efficiency analysis of ongoing FURI study. The development of this novel treatment is indicated for fungal treatment.
Key players in the market are focused on various growth strategies such as gaining product approval from regulatory authorities, in order to strengthen their market presence. For instance, in February 2018, Insmed, Inc., a biopharmaceutical company, received the U.S. Food and Drugs Administration (FDA) approval for new drug Arikayce (amikacin liposome inhalation suspension), which was approved limited population pathway for antibacterial and antifungal drugs program.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/anti-fungal-drugs-market-237

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snapshot, By Indication
  - Market Snapshot, By Dosage Form
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Market Trends
- Key Developments
- Impact Analysis
- Mergers & Acquisitions
- New Product Launch
- Technology Overview
- PEST Analysis
Global Antifungal Drugs Market, by COVID-19 Impact Analysis
- COVID 19 Impact Analysis
- New Developments
Global Antifungal Drugs Market, By Drug Type, 2016 – 2027, (US$ million)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Echinocandins
- Polyenes
- Allylamines
- Azoles
- Others
Global Antifungal Drugs Market, By Indication, 2016 – 2027, (US$ million)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Others
Global Antifungal Drugs Market, By Dosage Form, 2016 – 2027, (US$ million)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Powders
- Ointments
- Drugs
- Others
Global Antifungal Drugs Market, By Region, 2016– 2027, (US$ Million)
- Introduction
  - Market Share Analysis, By Drug Type, 2020 and 2027 (%)
  - Market Share Analysis, By Indication, 2020 and 2027 (%)
  - Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, By Region, 2017 – 2027
  - Regional Trends
- North America
  - Market Share Analysis, By Drug Type, 2020 and 2027 (%)
  - Market Share Analysis, By Indication, 2020 and 2027 (%)
  - Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - U.S.
    - Canada
- Europe
  - Market Share Analysis, By Drug Type, 2020 and 2027 (%)
  - Market Share Analysis, By Indication, 2020 and 2027 (%)
  - Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Share Analysis, By Drug Type, 2020 and 2027 (%)
  - Market Share Analysis, By Indication, 2020 and 2027 (%)
  - Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Share Analysis, By Drug Type, 2020 and 2027 (%)
  - Market Share Analysis, By Indication, 2020 and 2027 (%)
  - Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Africa
  - Market Share Analysis, By Drug Type, 2020 and 2027 (%)
  - Market Share Analysis, By Indication, 2020 and 2027 (%)
  - Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
  - Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
- Middle East
  - Market Share Analysis, By Drug Type, 2020 and 2027 (%)
  - Market Share Analysis, By Dosage Form, 2020 and 2027 (%)
  - Market Share Analysis, By Indication, 2020 and 2027 (%)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
Competitive Landscape
- Company Profiles
  - GlaxoSmithKline Plc
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Bayer AG
  - Abbott Laboratories
  - Merck & Co., Inc
  - Glenmark Pharmaceuticals Limited
  - Enzon Pharmaceuticals, Inc.
  - Pfizer Inc.
  - Gilead Sciences, Inc.
  - Sanofi S.A.
  - Astellas Pharma, Inc.
Section
- References
- Research Methodology
- About Us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

Company:
- CDN Newswire

Last Updated: 02-Mar-2021